Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
66,342,236
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
49,169,132
-
Shares change
-
+693,030
-
Total reported value, excl. options
-
$328,943,000
-
Value change
-
+$4,728,330
-
Put/Call ratio
-
235%
-
Number of buys
-
64
-
Number of sells
-
-74
-
Price
-
$6.69
Significant Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) as of Q3 2025
161 filings reported holding BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share as of Q3 2025.
Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,169,132 shares
of 66,342,236 outstanding shares and own 74% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (13,021,324 shares), Juniper Investment Company, LLC (6,939,357 shares), Nantahala Capital Management, LLC (5,810,662 shares), BlackRock, Inc. (3,068,948 shares), VANGUARD GROUP INC (2,924,788 shares), ROYCE & ASSOCIATES LP (1,262,976 shares), GEODE CAPITAL MANAGEMENT, LLC (1,100,850 shares), AMERICAN CENTURY COMPANIES INC (1,091,088 shares), Kent Lake PR LLC (1,000,200 shares), and STATE STREET CORP (876,434 shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.